Skip to main content
SpringerLink
Log in

A Method to Derive an Aggregated Score for Assessing Treatment Efficacy in Seasonal Allergic Conjunctivitis

  • Short Communication
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1
Fig. 2
Table III
Table IV

References

  1. A six-week, multicenter, double-masked, randomized, parallel-group, controlled study of the cution 0.1% compared to levocabastine ophthalmic suspension 0.05 % in patients with seasonal allergic conjunctivitis (SAC). Alcon Clinical Study Report n. 030:92:0900, Fort-Worth, Texas, USA

  2. Benzecri JP. L’Analyse de Données, Volume 2: L’Analyse des Correspondances. 2nd ed. Paris: Dunod, 1976

    Google Scholar 

  3. Lebart L, Morineau A, Piron M. Statistique Exploratoire Multi-dimentionelle. 3rd ed. Paris: Dunod, 2000

    Google Scholar 

  4. Greenacre M. Theory and application of correspondence analysis. London: Academic Press, 1984

    Google Scholar 

  5. Greenacre M. Correspondence analysis in practice. London: Academic Press, 1993

    Google Scholar 

  6. Greenacre M, Blasius J, editors. Correspondence analysis in social science. London: Academic Press, 1994

    Google Scholar 

  7. Scali J, Richard A, Gerber M. Diet profile in a population sample from Mediterranean Southern France. Public Health Nutr 2001; 4(2): 173–82

    Article  PubMed  CAS  Google Scholar 

  8. Grassi M, Gatto MR, Corrao G, et al. Development of a scoring system to assess disability in an Italian elderly population. Aging 1993; 5(2): 95–103

    PubMed  CAS  Google Scholar 

  9. Alcon Clinical Study Report. Protocol C-98-40, 2001.

  10. Butrus S, Greiner JV, Discepola M, et al. Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model. Clin Ther 2000 Dec; 22(12): 1462–72

    Article  PubMed  CAS  Google Scholar 

  11. Berdy GJ, Stoppel JO, Epstein AB. Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model. Clin Ther 2002 Jun; 24(6): 918–29

    Article  PubMed  CAS  Google Scholar 

  12. Spangler DL, Bensch G, Berdy GJ. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 2001 Aug; 23(8): 1272–80

    Article  PubMed  CAS  Google Scholar 

  13. Lanier BQ, Gross RD, Marks BB, et al. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms. Ann Allergy Asthma Immunol 2001 Jun; 86(6): 641–8

    Article  PubMed  CAS  Google Scholar 

  14. Berdy GJ, Spangler DL, Bensch G, et al. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Clin Ther 2000 Jul; 22(7): 826–33

    Article  PubMed  CAS  Google Scholar 

  15. Aguilar AJ. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate. Acta Ophthalmol Scand Suppl 2000 Jun; 230: 52–5

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was financially supported by Alcon Laboratories, Incorporated, Fort Worth, Texas, USA.

Author information

Authors and Affiliations

  1. University of Paris-Dauphine and CLP-Santé, 9–11 rue du Mont-Aigoual, 75015, Paris, France

    Claude Le Pen

  2. Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford

    Andrew F. Smith

  3. CLP-Santé, Paris, France

    Herve Lilliu & Gael Priol

  4. Alcon Laboratories Ltd, Hemel Hempstead, UK

    Andrew F. Smith

Authors
  1. Claude Le Pen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew F. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Herve Lilliu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gael Priol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claude Le Pen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Le Pen, C., Smith, A.F., Lilliu, H. et al. A Method to Derive an Aggregated Score for Assessing Treatment Efficacy in Seasonal Allergic Conjunctivitis. Clin. Drug Investig. 22, 783–789 (2002). https://doi.org/10.2165/00044011-200222110-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200222110-00006

Keywords

Search

Navigation